American Association for Cancer Research (AACR)
-
Publisher Of
-
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
Cancer Discovery.
9:220-229.
2019
-
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
24:4874-4886.
2018
-
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
24:4771-4784.
2018
-
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
24:4242-4255.
2018
-
Ex Vivo
Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.
Cancer Discovery.
8:196-215.
2018
-
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.
Cancer Discovery.
7:1266-1283.
2017
-
Oncogenic RAS Regulates Long Noncoding RNA Orilnc1
in Human Cancer.
Cancer Research.
77:3745-3757.
2017
-
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:2301-2310.
2016
-
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:935-947.
2016
-
Abstract A38: Identification through functional genomics screening of factors whose downregulation enhances the side population in ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:A38-A38.
2016
-
Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:A68-A68.
2016
-
Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:B27-B27.
2016
-
Abstract A092: Surpassing the emerging immune-checkpoint inhibitor market.
Cancer Immunology Research.
4:A092-A092.
2016
-
Abstract A157: Oncolytic poliovirus mediated immune events.
Cancer Immunology Research.
4:A157-A157.
2016
-
Abstract B140: Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: Analysis of data on the current use of HD IL-2.
Cancer Immunology Research.
4:B140-B140.
2016
-
Abstract B38: p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer.
Molecular Cancer Therapeutics.
14:B38-B38.
2015
-
Abstract A30: Using the principles of community-based participatory research to build an office of health equity within a nationally designated cancer institute.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23:A30-A30.
2014
-
Abstract B22: Altered methylation profiles of imprinted genes in response to prenatal exposure to cigarette smoke in the Newborn Epigenetic STudy (NEST) cohort.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23:B22-B22.
2014
-
Abstract C16: Feasibility study: Protein profiling of primary breast cancers from premenopausal women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23:C16-C16.
2014
-
S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer.
Molecular Cancer Research : Mcr.
11:1542-1553.
2013
-
Abstract B151: Monitoring tumor microenvironment (Hb saturation and oxygenation) in response to plasmonics-assisted photothermal cancer therapy..
Molecular Cancer Therapeutics.
12:B151-B151.
2013
-
Abstract C248: Novel PORCN inhibitors are safe and effective in the treatment of WNT-dependent cancers..
Molecular Cancer Therapeutics.
12:C248-C248.
2013
-
Abstract C61: Phase I Study of pazopanib in combination with the investigational hypoxia-targeted drug TH-302..
Molecular Cancer Therapeutics.
12:C61-C61.
2013
-
Abstract C85: Drug interaction study of tivantinib in cancer subjects using a cocktail approach..
Molecular Cancer Therapeutics.
12:C85-C85.
2013
-
Abstract A83: Induction of PD-L1 expression by cytotoxic agents through activation of NF-kB signal.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
19:A83-A83.
2013
-
Abstract B19: Functional genomics approach links anchorage-independence with tumor dormancy in ovarian cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
19:B19-B19.
2013
-
Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
19:PR08-PR08.
2013
-
Abstract A18: Genetic elements of cancer cell survival in tumor microenvironment stresses.
Molecular Cancer Therapeutics.
12:A18-A18.
2013
-
A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent.
Molecular Cancer Research : Mcr.
11:219-229.
2013
-
Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells.
Cancer Research.
72:5625-5634.
2012
-
Correction: Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells.
Cancer Research.
71:6084-6084.
2011
-
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines.
Cancer Research.
69:3356-3363.
2009
-
Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on Androgen-Regulated Transcription in Prostate Cancer Cells.
Cancer Research.
69:3140-3147.
2009
-
Abstract SS02-02: A long walk from FGFR2 alternative splicing to cancer progression.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23.
2014
-
Abstract PO-232: Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract 101: The Tanzanian Pediatric Cancer Network: A Comprehensive Evaluation of the Incidence of Presenting Patients and Access to Pediatric Cancer Care in Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
101-101.
2021
-
Abstract 102: Breakpoints in Protocol Compliance and Their Influence on Outcomes for Children with Wilms Tumor in Northern Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
102-102.
2021
-
Abstract 112: Use of WhatsApp to Improve Medical Provider Communication for Children with Wilms Tumor in Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
112-112.
2021
-
Abstract 4: Impact of Immunohistochemistry on Diagnostic Accuracy for Pediatric Cancer in Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
4-4.
2021
-
Abstract 3882: YAP1 and WWTR1 (TAZ) positively regulate PAX3-FOXO1 transcriptional programming in fusion-positive rhabdomyosarcoma.
Cancer Research.
3882-3882.
2020
-
Abstract IA06: Dysregulated Hippo signaling in childhood rhabdomyosarcoma.
Molecular Cancer Research : Mcr.
IA06-IA06.
2020
-
Abstract A023: Results from a town hall meeting: Inflammatory breast cancer listening session led by KOMEN scholars.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A023-A023.
2020
-
Abstract A038: Current unmet needs in inflammatory breast cancer/IBC patient care: Analysis of open-ended responses from a community engagement session of clinicians, researchers, advocates, and patients at the Duke Consortium for IBC conference.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A038-A038.
2020
-
Abstract A043: Cancer care in people with HIV: Identifying adherence challenges to improve outcomes.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A043-A043.
2020
-
Abstract A076: Adherence to adjuvant endocrine therapy: Do racial disparities persist among the insured?.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A076-A076.
2020
-
Abstract A080: Rates of Invitation, participation, and willingness to engage in medical and clinical research: Findings from attendees at two gender-specific community-based screening programs.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A080-A080.
2020
-
Abstract A114: Characterization of a metastatic prostate cancer xenograft derived from a patient of African ancestry.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A114-A114.
2020
-
Abstract A50: Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A50-A50.
2020
-
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B006-B006.
2020
-
Abstract B034: Improving patient-centered care for inflammatory breast cancer: Strategies for addressing barriers faced by patients, researchers, and providers.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B034-B034.
2020
-
Abstract B035: Identification of a tumor cell adaptive stress response signaling pathway, which drives aggressive breast cancer phenotype and therapeutic resistance, in African American patients with locally advanced breast cancer subtypes.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B035-B035.
2020
-
Abstract B050: Identification of differentially expressed and spliced genes between breast, colon, lung, and prostate cancer from African American and white patients.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B050-B050.
2020
-
Abstract B061: Mechanistic and functional interrogation of novel ancestry-related alternatively spliced androgen receptor signal genes in prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B061-B061.
2020
-
Abstract B063: Race-related LMO7
exon skipping enhances prostate tumor invasion.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B063-B063.
2020
-
Abstract B064: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B064-B064.
2020
-
Abstract B071: Genomic differences between non-small cell lung cancer (NSCLC) in African American and white patients.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B071-B071.
2020
-
Abstract B088: Health insurance status, stage at presentation and survival among female patients with head and neck cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B088-B088.
2020
-
Abstract C007: Racial differences in feasibility and perceived value of electronic symptom monitoring in a cohort of Black and White bladder and prostate cancer patients.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C007-C007.
2020
-
Abstract C038: First- and second-degree family history of ovarian and breast cancers in relation to risk of invasive ovarian cancer in African American and White women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C038-C038.
2020
-
Abstract C044: Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C044-C044.
2020
-
Abstract C070: Racial disparities in body mass index and ovarian cancer risk in the OCWAA Consortium.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C070-C070.
2020
-
Abstract D010: Developing an inflammatory breast cancer campaign: Results from focus groups led by Komen scholars.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D010-D010.
2020
-
Abstract D064: Race-related RNA splicing dysregulation of PI3Kd signaling: A therapeutic target for aggressive prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D064-D064.
2020
-
Abstract D071: Impact of racial differences in financial burden on time to treatment.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D071-D071.
2020
-
Abstract D084: Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)—final PROCEED analysis.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D084-D084.
2020
-
Abstract D093: Who carries the excess cancer risk burden: Implications of disparities in polycyclic aromatic hydrocarbon exposure.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D093-D093.
2020
-
Abstract IA18: North Carolina Central University and Duke Cancer Institute's collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagement.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
IA18-IA18.
2020
-
Abstract PR11: Racial differences in characteristics of early- vs. late-onset colorectal cancer among veterans.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
PR11-PR11.
2020
-
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a United States Prospective Cohort Consortium.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
690-690.
2020
-
Abstract GS2-05: Microscaled proteogenomic methods for precision oncology.
Cancer Research.
2020
-
Abstract OT1-05-01: The incidence of febrile neutropenia (FN) for chemotherapy patients receiving pegfilgrastim by an on-body injector (pegfilgrastim OBI) versus other FN prophylaxis strategies.
Cancer Research.
2020
-
Abstract P1-03-03: Multichannel serial imaging of transgenic, preclinical murine models provides the first quantitative analysis of the unusual growth kinetics and lymph-vascular invasion of patient-derived inflammatory breast cancer cells and tumor emboli.
Cancer Research.
2020
-
Abstract P1-06-02: Characterization of gene- and sample-level APOBEC mutagenesis enrichment with respect to intrinsic subtypes, tumor mutational burden, and immune composition in breast cancer.
Cancer Research.
2020
-
Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts.
Cancer Research.
2020
-
Abstract P1-21-07: The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions.
Cancer Research.
2020
-
Abstract P2-10-18: Deciphering racial disparities in breast cancer collagen reorganization by targeted extracellular matrix proteomics.
Cancer Research.
2020
-
Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer.
Cancer Research.
2020
-
Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer.
Cancer Research.
2020
-
Abstract P4-05-03: Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).
Cancer Research.
2020
-
Abstract P4-12-10: Clinical implementation of the machine learning-based automated treatment planning tool for whole breast radiotherapy.
Cancer Research.
2020
-
Abstract P5-14-07: Avoidable acute care involving chemotherapy-induced nausea and vomiting (CINV) among patients with breast cancer receiving anthracycline + cyclophosphamide (AC) with NEPA prophylaxis relative to other antiemetics: An external control arm analysis.
Cancer Research.
2020
-
Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?.
Cancer Research.
2020
-
Abstract P5-14-17: Musculoskeletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrogen receptor positive DCIS: CALGB 40903 (Alliance).
Cancer Research.
2020
-
Abstract P5-14-18: Cardioprotective therapy in breast cancer patients with subclinical and clinical cardiotoxicty.
Cancer Research.
2020
-
Abstract PD10-10: Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy.
Cancer Research.
2020
-
Abstract A074: Correlation of homologous recombination deficiency (HRD) status by BROCA-HR sequencing with response to combination cediranib and olaparib in relapsed ovarian cancer.
Molecular Cancer Therapeutics.
A074-A074.
2019
-
Abstract P1-06-04: Small-molecule screening nominates diverse combination therapies that sensitize BRCA mutant and wild-type triple negative breast cancer to PARP inhibition.
Cancer Research.
2019
-
Abstract P2-09-16: CD8 T cells induced by novel alphaviral vector predict improved progression free survival in advanced HER2+ breast cancer patients.
Cancer Research.
2019
-
Abstract P3-06-12: Genetic heterogeneity of DCIS is a predictor of invasive cancer.
Cancer Research.
2019
-
Abstract P3-08-07: Distinct biological signatures describe differences in BRCA mutated subgroups.
Cancer Research.
2019
-
Abstract P4-09-08: Shared-patient physician networks and their impact on the uptake of genomic testing in early-stage breast cancer.
Cancer Research.
2019
-
Abstract P4-16-05: Avoidable acute care use associated with nausea and emesis among patients receiving AC, carboplatin, or cisplatin for breast cancer.
Cancer Research.
2019
-
Abstract P4-16-09: Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy.
Cancer Research.
2019
-
Abstract PD6-08: Medicare costs for women after breast cancer: Preparing for survivorship.
Cancer Research.
2019
-
Abstract A22: Augmentation of a novel adenoviral vaccine strategy by checkpoint inhibitors.
Cancer Immunology Research.
A22-A22.
2018
-
Abstract A79: Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of antigen-presenting cells and tumor antigen-specific CTLs.
Cancer Immunology Research.
A79-A79.
2018
-
Abstract B66: Targeted activation of innate immune adaptors MAVS and STING promotes antitumor responses in colorectal cancer models.
Cancer Immunology Research.
B66-B66.
2018
-
Abstract B166: Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma.
Molecular Cancer Therapeutics.
B166-B166.
2018
-
Abstract CN02-02: Immunotherapy for central nervous system cancers.
Molecular Cancer Therapeutics.
2018
-
Abstract A03: Several rational combination kinase inhibitor treatments identified by synthetic lethality screens are efficacious in intracranial triple negative breast cancer models.
Molecular Cancer Therapeutics.
A03-A03.
2017
-
Abstract PR18: Leveraging synthetic lethality to target convergent therapeutic resistance.
Molecular Cancer Therapeutics.
PR18-PR18.
2017
-
Abstract 666: CD37 tetraspanin as a novel biomarker for PD-1 blockade in diffuse large B-cell lymphoma.
Cancer Research.
666-666.
2017
-
Abstract IA17: Non-canonical aspects of ATM and p53 signaling pathways.
Molecular Cancer Research : Mcr.
IA17-IA17.
2017
-
Abstract A38: Checkpoint blockade elicits unique T cell expansion to promote tumor regression.
Cancer Immunology Research.
A38-A38.
2017
-
Abstract B04: Intralesional vaccination with Ad-MAVS alters the immunosuppressive tumor microenvironment and elicits robust anti-tumor immunity in non-immunogenic cancers.
Cancer Immunology Research.
B04-B04.
2017
-
Abstract B36: Modulating the tumor microenvironment to enhance cancer immunotherapy by inducing phosphatidylserine expression on the tumor surface.
Cancer Immunology Research.
B36-B36.
2017
-
Abstract P4-19-01: Non-metastatic and metastatic breast cancer patients' priorities when considering a treatment decision.
Cancer Research.
2017
-
Abstract B44: Immune pathway dysregulations in inflammatory breast cancer health disparity.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B44-B44.
2017
-
Abstract B51: Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B51-B51.
2017
-
Abstract B58: Single-nucleotide polymorphisms of race-related alternatively spliced genes associate with prostate cancer risk, aggressiveness and/or survival.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B58-B58.
2017
-
Abstract B78: The interplay between smoking at diagnosis, marital status, and head and neck cancer survivorship.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B78-B78.
2017
-
Abstract B79: Disparities in HPV vaccine initiation and completion based on sexual orientation among women in the United States.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B79-B79.
2017
-
Abstract A032: Using oncolytic polio expressing tumor as a cancer vaccine.
Cancer Immunology Research.
A032-A032.
2016
-
Abstract A51: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine in a national sample of U.S. adults.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A51-A51.
2016
-
Abstract A52: Sociodemographic predictors of HPV and HPV vaccine knowledge and awareness among Americans who use the Internet as their primary source of health information.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A52-A52.
2016
-
Abstract A60: A paradox: Engaging in at-risk behavior may not correlate with perceived susceptibility to cancer or heart disease.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A60-A60.
2016
-
Abstract A73: Obesity, weight gain, and ovarian cancer risk in African American women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A73-A73.
2016
-
Abstract B18: Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer in men of African descent.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B18-B18.
2016
-
Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B40-B40.
2016
-
Abstract B58: Assessing university students' sexual risk behavior, knowledge of the human papillomavirus, (HPV), HPV vaccine, and association between HPV and head and neck cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B58-B58.
2016
-
Abstract B70: Characteristics, risk perception, and predictors of oral cancer knowledge among drag racers and their fans.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B70-B70.
2016
-
Abstract B89: HPV is not just a woman's business! Understanding the gaps in men's knowledge of HPV and HPV vaccine.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B89-B89.
2016
-
Abstract C47: Gender and racial disparities in long-term survival of oral and oropharyngeal cancer in the United States.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C47-C47.
2016
-
Abstract IA09: Intervening on the financial toxicity of cancer care.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
IA09-IA09.
2016
-
Abstract PR05: Dietary quality and ovarian cancer risk in African American women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
PR05-PR05.
2016
-
Abstract A30: Frizzled-7 (FZD7)-mediated non-canonical Wnt-Planar Cell Polarity (PCP) signalling pathway as a novel molecular driver for the C5/Proliferative/Stem-A molecular subtype of ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A30-A30.
2016
-
Abstract B63: Expression of VEGF in ovarian cancer suppresses tumor immunity through recruitment of myeloid derived suppressor cells..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
B63-B63.
2016
-
Abstract A24: The dual PI3K δ/γ inhibitor, RP6530, in combination with ibrutinib or fludarabine, synergistically enhances cytotoxicity in primary CLL cells in vitro..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A24-A24.
2015
-
Abstract POSTER-BIOL-1319: Temporal shifts in the epigenetic regulation of tight junctions from primary to recurrent ovarian cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
2015
-
Abstract POSTER-TECH-1123: Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic changes.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
2015
-
Abstract POSTER-THER-1420: Ascites drives ovarian cancer stem-like cell growth: therapeutic opportunities.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
2015
-
Acculturation and Ethnic Variations in Breast Cancer Risk Factors, Gail Model Risk Estimates and Mammographic Breast Density.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
760-760.
2015
-
Abstract A23: Oncogenic Ras induces inflammatory cytokine production by upregulating squamous cell carcinoma antigen (SerpinB3).
Molecular Cancer Research : Mcr.
A23-A23.
2014
-
Abstract B05: MRI provides a more reliable method of esophageal tumor detection than endoscopy in a rat model.
Molecular Cancer Research : Mcr.
B05-B05.
2014
-
Abstract C263: mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1..
Molecular Cancer Therapeutics.
C263-C263.
2013
-
Abstract C86: Tethered Hsp90 inhibitors carrying optical or radioiodinated probes reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells..
Molecular Cancer Therapeutics.
C86-C86.
2013
-
Predictors of Colorectal Cancer Surveillance among Radiation-treated Survivors of Childhood Cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
478-478.
2013
-
Abstract B35: Altered DNA methylation at imprinted insulin-like growth factor-2 (IGF2) resulting from heavy metal exposure in vitro and in vivo in infants from the Newborn Epigenetic STudy (NEST)..
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B35-B35.
2012
-
Abstract A10: Antiangiogenic therapy (VEGF-R1–3 and PDGFR inhibitor) increases tumor hemoglobin saturation and decreases interstitial pressure, and microvessel density.
Molecular Cancer Therapeutics.
A10-A10.
2009
-
Abstract A7: Targeting the tumor microenvironment via
inhibition of VEGF and PDGF to improve liposomal drug delivery in human non-small cell lung cancer xenografts.
Molecular Cancer Therapeutics.
A7-A7.
2009
-
Abstract B264: IC261 induces cell cycle arrest and apoptosis of human cancer cells via a CK1δ/ε independent mechanism.
Molecular Cancer Therapeutics.
B264-B264.
2009